1.7900
+0.0200
+(1.13%)
At close: April 17 at 4:00:01 PM EDT
1.8300
+0.04
+(2.23%)
After hours: April 17 at 7:54:45 PM EDT
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
325,558
375,225
421,212
304,465
Total Liabilities Net Minority Interest
37,940
60,640
79,839
70,158
Total Equity Gross Minority Interest
287,618
314,585
341,373
234,307
Total Capitalization
287,618
314,585
341,373
234,307
Common Stock Equity
287,618
314,585
341,373
234,307
Capital Lease Obligations
23,164
25,561
25,796
13,850
Net Tangible Assets
65,579
75,139
90,152
-25,993
Working Capital
53,050
71,785
98,928
1,965
Invested Capital
287,618
314,585
341,373
234,307
Tangible Book Value
65,579
75,139
90,152
-25,993
Total Debt
23,164
25,561
25,796
13,850
Share Issued
120,222.5470
116,859.4680
115,218.2290
114,820.8590
Ordinary Shares Number
120,222.5470
116,859.4680
115,218.2290
114,820.8590
12/31/2021 - 9/30/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LGND Ligand Pharmaceuticals Incorporated
104.97
+0.33%
UPB Upstream Bio, Inc.
8.78
+4.28%
SLRN Acelyrin, Inc.
2.2000
0.00%
OBIO Orchestra BioMed Holdings, Inc.
2.8500
-0.35%
ZURA Zura Bio Limited
1.2300
+6.96%
OCTHF Oxford Cannabinoid Technologies Holdings Plc
0.0028
0.00%
FNAM Evolutionary Genomics, Inc.
0.0002
0.00%
RDTCF Rapid Dose Therapeutics Corp.
0.0080
0.00%
BXPHF Botanix Pharmaceuticals Limited
0.2300
0.00%
A71.F Ascendis Pharma A/S
140.00
+6.06%